Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure

J Int Med Res. 2022 Dec;50(12):3000605221139711. doi: 10.1177/03000605221139711.

Abstract

Objective: To define which oxidative stress markers could be used as diagnostic tools in the assessment of post-infarction heart failure (HF).

Methods: This observational study enrolled patients with HF that were divided into three subgroups (ejection fraction [EF] ≥ 50%; EF 40-49%; EF < 40%) and age- and sex-matched healthy control subjects. The plasma concentrations of advanced oxidation protein products (AOPP), thiobarbituric acid reactive substances, catalase activity and free thiols were determined in all participants.

Results: The study enrolled 81 patients with HF and 68 healthy control subjects. There were significant differences in the values ​​of oxidative stress markers between patients and controls. Oxidative stress parameters did not differ between the subgroups of patients, except for AOPP, which was significantly higher in the EF < 40% group. Univariate and multivariate logistic regression analyses showed an association between AOPP and HF in the EF ≥ 50% group, while receiver operating characteristic (ROC) curve analysis identified a cut-off value of 60.89 µmol/l for AOPP.

Conclusions: Based on the ROC curve analysis of AOPP and the higher significance in the multivariate analyses for patients with EF ≥ 50%, these current results suggest that AOPP could be a useful additional tool in the assessment of post-infarction HF.

Keywords: Post-infarction heart failure; advanced oxidation protein products; ejection fraction; oxidative stress.

Publication types

  • Observational Study

MeSH terms

  • Advanced Oxidation Protein Products* / metabolism
  • Biomarkers
  • Heart Failure* / complications
  • Heart Failure* / diagnosis
  • Humans
  • Infarction
  • Oxidation-Reduction
  • Oxidative Stress

Substances

  • Biomarkers
  • Advanced Oxidation Protein Products